Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 1,189,241 | 2,188,388 (0%) | 0% | 0 | Common Stock | |
| Tscan Therapeutics Inc | Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 1,165,000 | 1,165,000 | - | - | Stock Option (Right to Buy) | |
| Acadia Healthcare Co Inc | Debra K. Osteen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 1,125,000 | 1,125,000 | - | - | Stock Option (Right to Buy) | |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 966,433 | 1,932,866 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 950,000 | 950,000 | - | - | Stock Options (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 950,000 | 950,000 | - | - | Stock Options (right to buy) | |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 807,776 | 807,776 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| American Eagle Outfitters Inc | Jay L. Schottenstein | Director, Exec Chairman & CEO | Sale of securities on an exchange or to another person at price $ 25.83 per share. | 20 Jan 2026 | 527,343 | 6,408,231 (3%) | 0% | 25.8 | 13,621,270 | Common Stock, without par value |
| Gamestop Corp (Class A) | Ryan Cohen | Director, President, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 21.60 per share. | 20 Jan 2026 | 500,000 | 38,347,842 (58%) | 0% | 21.6 | 10,800,500 | Class A Common Stock, $0.001 par value per share |
| Gamestop Corp (Class A) | Ryan Cohen | Director, President, CEO and Chairman | Purchase of securities on an exchange or from another person at price $ 21.12 per share. | 20 Jan 2026 | 500,000 | 37,847,842 (57%) | 0% | 21.1 | 10,558,700 | Class A Common Stock, $0.001 par value per share |
| American Eagle Outfitters Inc | Jay L. Schottenstein | Director, Exec Chairman & CEO | Sale of securities on an exchange or to another person at price $ 25.27 per share. | 20 Jan 2026 | 500,000 | 6,935,574 (4%) | 0% | 25.3 | 12,635,000 | Common Stock, without par value |
| Acumen Pharma Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Tscan Therapeutics Inc | Chrystal U. Louis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 420,000 | 420,000 | - | - | Stock Option (Right to Buy) | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 365,422 | 1,530,240 (1%) | 0% | 0 | Common Stock | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 20 Jan 2026 | 353,321 | 8,091,795 | - | 0.5 | 175,000 | Common Stock, par value $.001 |
| Tscan Therapeutics Inc | Jason A. Amello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 331,674 | 345,572 (3%) | 3% | 0 | Common Stock | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 325,203 | 339,101 (3%) | 3% | 0 | Common Stock | |
| Acumen Pharma Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 299,800 | 893,310 | - | 0 | Common Stock | |
| Prologis | Hamid R. Moghadam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 220,000 | 1,332,743 | - | - | LTIP Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.37 per share. | 20 Jan 2026 | 200,024 | 1,561,976 | - | 32.4 | 6,475,577 | Class A Common Stock |
| Snowflake Inc (Class A) | Frank Slootman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 200,000 | 6,736,655 | - | - | Stock Option (Right to Buy) | |
| Snowflake Inc (Class A) | Frank Slootman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share. | 20 Jan 2026 | 200,000 | 250,329 | - | 8.9 | 1,776,000 | Common Stock |
| Grindr Inc (Class A) | Fu Bin James Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.98 per share. | 20 Jan 2026 | 200,000 | 21,133,867 | - | 12.0 | 2,396,000 | Common Stock |
| Grindr Inc (Class A) | Fu Bin James Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.99 per share. | 20 Jan 2026 | 200,000 | 21,333,867 | - | 12.0 | 2,398,000 | Common Stock |
| Grindr Inc (Class A) | Fu Bin James Lu | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.06 per share. | 20 Jan 2026 | 200,000 | 21,533,867 | - | 12.1 | 2,412,000 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.37 per share. | 20 Jan 2026 | 199,630 | 1,562,370 | - | 32.4 | 6,462,622 | Class A Common Stock |
| Chimera Investment Corp | Phillip J. Kardis | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 194,774 | 695,495 (0%) | 0% | 0 | Common Stock | |
| Rithm Cap Corp | Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 169,885 | 278,011 (0%) | 0% | 0 | Common Stock | |
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 20 Jan 2026 | 167,926 | 167,926 | - | - | Series A Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | 20 Jan 2026 | 167,926 | 69,106,164 | - | - | Series B Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Andrew Bialecki | Director, Co-Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.16 per share. | 20 Jan 2026 | 167,130 | 796 | - | 24.2 | 4,037,861 | Series A Common Stock |
| Lennar (Class A) | Stuart A. Miller | Director, Executive Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 161,083 | 1,125,122 (0%) | 0% | 0 | Class A Common Stock | |
| SBA Communications (Class A) | Jeffrey A. Stoops | Director, CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.30 per share. | 20 Jan 2026 | 149,446 | 269,648 (0%) | 0% | 182.3 | 27,244,006 | Class A Common Stock |
| SBA Communications (Class A) | Jeffrey A. Stoops | Director, CHAIRMAN | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 149,446 | 0 | - | - | Stock Options (Right to Buy) | |
| SBA Communications (Class A) | Jeffrey A. Stoops | Director, CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.11 per share. | 20 Jan 2026 | 143,622 | 126,026 (0%) | 0% | 194.1 | 27,878,466 | Class A Common Stock |
| Siebert Fin Corp | Gloria E. Gebbia | Director, Ten Percent Owner, Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 140,000 | 9,833,494 (32%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Siebert Fin Corp | John J. Gebbia | Director, CEO, Ten Percent Owner, Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 140,000 | 9,833,494 (32%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Citigroup | Viswas Raghavan | Head of Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 135,838 | 569,048 (0%) | 0% | 118.0 | 16,034,352 | Common Stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 133,595 | 587,226 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Brendan M. O'Malley | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 113,949 | 464,712 (0%) | 0% | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 102,835 | 8,602,980 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 102,835 | 351,499 | - | - | Class A Common Stock | ||
| Tscan Therapeutics Inc | Leiden Dworak | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Tamboran Resources Corp | David N. Siegel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 100,000 | 113,000 | - | 0 | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 96,578 | 0 (0%) | 0% | 0 | Common Stock | |
| AT&T | John T. Stankey | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 96,578 | 1,056,225 (0%) | 0% | 0 | Common Stock | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 20 Jan 2026 | 95,831 | 1,956,101 | - | 27.0 | 2,587,197 | Class A Common Stock |
| JPMC | James S. Dimon | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 90,000 | 1,667,862 (0%) | 0% | 0 | Common Stock | |
| Hewlett Packard | Marie Myers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.39 per share. | 20 Jan 2026 | 89,898 | 333,713 (0%) | 0% | 20.4 | 1,833,020 | Common Stock |
| Hewlett Packard | Marie Myers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 89,898 | 89,896 | - | - | Restricted Stock Units | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 20 Jan 2026 | 89,375 | 505,601 | - | 1.3 | 114,400 | Common Stock |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.04 per share. | 20 Jan 2026 | 89,139 | 332,754 (0%) | 0% | 30.0 | 2,677,736 | Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.16 per share. | 20 Jan 2026 | 83,641 | 542,071 (0%) | 0% | 5.2 | 431,470 | Class A Common Stock |
| Lindblad Expeditions Holdings Inc | Sven-Olof Lindblad | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 20 Jan 2026 | 80,520 | 11,703,442 (23%) | 0% | 15.7 | 1,261,652 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 20 Jan 2026 | 76,967 | 3,166,604 | - | 6.5 | 503,364 | Common Stock |
| Snowflake Inc (Class A) | Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 206.67 per share. | 20 Jan 2026 | 76,672 | 130,488 | - | 206.7 | 15,845,726 | Common Stock |
| Abeona Therapeutics Inc | Madhav Vasanthavada | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 76,621 | 331,229 (0%) | 0% | 0 | Common Stock | |
| Lindblad Expeditions Holdings Inc | Sven-Olof Lindblad | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 20 Jan 2026 | 75,314 | 11,628,128 (23%) | 0% | 16.0 | 1,207,652 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 7.88 per share. | 20 Jan 2026 | 75,000 | 3,091,604 | - | 7.9 | 590,933 | Common Stock |
| Snowflake Inc (Class A) | Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 207.48 per share. | 20 Jan 2026 | 74,830 | 55,658 | - | 207.5 | 15,525,504 | Common Stock |
| Natera Inc | Steven Leonard Chapman | Director, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 71,932 | 217,354 (0%) | 0% | 234.7 | 16,885,203 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 69,421 | 69,421 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 69,421 | 230,953 (0%) | 0% | - | Common Stock | |
| Lennar (Class A) | Stuart A. Miller | Director, Executive Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 69,035 | 1,194,157 (0%) | 0% | 0 | Class A Common Stock | |
| Hewlett Packard | Marie Myers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.39 per share. | 20 Jan 2026 | 68,493 | 271,145 (0%) | 0% | 20.4 | 1,396,572 | Common Stock |
| Hewlett Packard | Marie Myers | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 68,493 | 68,492 | - | - | Restricted Stock Units | |
| Citigroup | Jane Nind Fraser | Director, Chair & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 67,967 | 818,055 (0%) | 0% | 118.0 | 8,022,932 | Common Stock |
| Innovative Industrial Properties Inc | Alan D. Gold | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 66,702 | 66,702 | - | - | Restricted Stock Units 2026 | |
| Royalty Pharma PLC (Class A) | Terrance Coyne | EVP & CFO | Sale of securities on an exchange or to another person at price $ 39.35 per share. | 20 Jan 2026 | 65,832 | 394,996 | - | 39.3 | 2,590,384 | Class A Ordinary Shares |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 65,737 | 4,243,659 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 63,985 | 183,618 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 63,985 | 127,974 | - | - | Restricted Stock Unit | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 61,314 | 2,140,525 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 61,314 | 61,316 | - | - | Earnout - Class A Shares | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. | 20 Jan 2026 | 60,216 | 118,598 | - | 9.3 | 557,600 | Ordinary Shares |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 60,216 | 702,598 | - | - | Option (Right to Buy) | |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.23 per share. | 20 Jan 2026 | 60,000 | 134,201 (0%) | 0% | 60.2 | 3,613,800 | Common Shares |
| SBA Communications (Class A) | Brendan T. Cavanagh | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 55,741 | 0 | - | - | Stock Options (Right to Buy) | |
| SBA Communications (Class A) | Brendan T. Cavanagh | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.30 per share. | 20 Jan 2026 | 55,741 | 105,733 (0%) | 0% | 182.3 | 10,161,584 | Class A Common Stock |
| Citigroup | Jane Nind Fraser | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 55,000 | 1,055,000 | - | - | Employee Stock Options (Right to Buy) | |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Sale of securities on an exchange or to another person at price $ 27.04 per share. | 20 Jan 2026 | 54,900 | 2,051,932 | - | 27.0 | 1,484,606 | Class A Common Stock |
| Chimera Investment Corp | Subramaniam Viswanathan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 54,537 | 247,826 (0%) | 0% | 0 | Common Stock | |
| SBA Communications (Class A) | Brendan T. Cavanagh | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.11 per share. | 20 Jan 2026 | 53,792 | 51,941 (0%) | 0% | 194.1 | 10,441,565 | Class A Common Stock |
| Dave & Buster`s Entertainment Inc | Kevin M. Sheehan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 50,000 | 39,645 (0%) | 0% | 0 | Common Stock | |
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 20 Jan 2026 | 50,000 | 50,000 | - | 0 | Class A Common Stock | ||
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | 20 Jan 2026 | 50,000 | 825,213 | - | - | The Hagerty Group, LLC Units | ||
| Hagerty Inc (Class A) | Kenneth Ahn | President, Hagerty Marketplace | Sale of securities on an exchange or to another person at price $ 12.55 per share. | 20 Jan 2026 | 50,000 | 0 | - | 12.6 | 627,500 | Class A Common Stock |
| FREYR Battery | Mingxing Lin | Director | Other type of transaction at price $ 0.00 per share. | 20 Jan 2026 | 50,000 | 431,800 | - | - | Common Stock | |
| Innovative Industrial Properties Inc | Paul E. Smithers | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 47,643 | 150,577 (0%) | 0% | - | Common Stock | |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 45,395 | 0 | - | - | Stock Unit (SIP) | |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 45,395 | 494,838 (0%) | 0% | 36.9 | 1,675,546 | Common Stock |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 44,000 | 254,984 | - | - | Class B Common Stock | |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.55 per share. | 20 Jan 2026 | 44,000 | 0 | - | 7.5 | 332,059 | Class A Common Stock |
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 20 Jan 2026 | 44,000 | 44,000 | - | - | Class A Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 20 Jan 2026 | 44,000 | 210,984 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 44,000 | 268,851 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| Snowflake Inc (Class A) | Frank Slootman | Director | Sale of securities on an exchange or to another person at price $ 205.46 per share. | 20 Jan 2026 | 43,169 | 207,160 | - | 205.5 | 8,869,373 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.42 per share. | 20 Jan 2026 | 42,740 | 341,960 | - | 32.4 | 1,385,451 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.41 per share. | 20 Jan 2026 | 42,632 | 342,068 | - | 32.4 | 1,381,861 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 95.55 per share. | 20 Jan 2026 | 41,445 | 268,866 | - | 95.6 | 3,960,078 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 41,259 | 400,000 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 20 Jan 2026 | 41,259 | 583,330 (1%) | 0% | 3.8 | 156,784 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 20 Jan 2026 | 41,259 | 542,071 (0%) | 0% | 5.3 | 220,463 | Class A Common Stock |
| Alx Oncology Holdings Inc | Corey S. Goodman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Chris H. Takimoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock option (right to buy) | |
| Alx Oncology Holdings Inc | Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock option (right to buy) | |
| Waystar Holding Corp | Eric L. Sinclair III | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 20 Jan 2026 | 40,225 | 474,826 | - | 30.1 | 1,210,077 | Common Stock |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. | 20 Jan 2026 | 40,066 | 552,777 | - | 3.0 | 118,195 | Class A Common Stock |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 40,066 | 1,335,743 | - | - | Stock Option | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 20 Jan 2026 | 40,000 | 953,839 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | 20 Jan 2026 | 40,000 | 4,623,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 20 Jan 2026 | 40,000 | 913,839 | - | 4.5 | 178,800 | Class A Common Stock |
| Rithm Cap Corp | Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 39,961 | 79,919 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 39,784 | 662,814 | - | - | Option (Right to Buy) | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. | 20 Jan 2026 | 39,784 | 98,166 | - | 9.3 | 368,400 | Ordinary Shares |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.41 per share. | 20 Jan 2026 | 39,768 | 143,850 | - | 203.4 | 8,089,209 | Class A Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.78 per share. | 20 Jan 2026 | 39,712 | 77,986 | - | 31.8 | 1,262,047 | Ordinary Shares |
| Minerals Tech Inc | Douglas T. Dietrich | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 39,000 | 102,253 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 37,069 | 37,069 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 37,069 | 161,532 (0%) | 0% | - | Common Stock | |
| Natera Inc | Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 242.67 per share. | 20 Jan 2026 | 36,573 | 64,123 (0%) | 0% | 242.7 | 8,875,115 | Common Stock |
| Hewlett Packard | Marie Myers | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.39 per share. | 20 Jan 2026 | 35,376 | 298,337 (0%) | 0% | 20.4 | 721,317 | Common Stock |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.17 per share. | 20 Jan 2026 | 34,799 | 196,154 (0%) | 0% | 4.2 | 145,112 | Common Stock |
| Protagonist Therapeutics Inc | Dinesh V. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.48 per share. | 20 Jan 2026 | 34,438 | 580,505 (2%) | 0% | 82.5 | 2,840,446 | Common Stock |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP Intl | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 34,376 | 0 (0%) | 0% | 0 | Common Stock | |
| AT&T | Lori M. Lee | Global Mktg Ofr & SEVP Intl | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 34,376 | 127,800 (0%) | 0% | 0 | Common Stock | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.11 per share. | 20 Jan 2026 | 33,838 | 658,807 (0%) | 0% | 46.1 | 1,560,131 | Common Stock |
| Citigroup | Nicole Giles | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 33,835 | 97,347 (0%) | 0% | 118.0 | 3,993,966 | Common Stock |
| Planet Labs PBC (Class A) | Ashley Fieglein Johnson | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.38 per share. | 20 Jan 2026 | 33,693 | 2,106,832 | - | 26.4 | 888,821 | Class A Common Stock |
| Minerals Tech Inc | Douglas T. Dietrich | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 33,494 | 33,494 | - | - | Employee Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Jason Shand Robins | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Waystar Holding Corp | Eric L. Sinclair III | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.14 per share. | 20 Jan 2026 | 32,663 | 515,051 | - | 4.1 | 135,225 | Common Stock |
| Waystar Holding Corp | Eric L. Sinclair III | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 32,663 | 6,141 | - | - | Stock Options (right to buy) | |
| Pinterest Inc (Class A) | William J. Ready | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.39 per share. | 20 Jan 2026 | 32,382 | 1,302,493 (0%) | 0% | 25.4 | 822,179 | Class A Common Stock |
| MBX Biosciences Inc | Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 32,000 | 32,000 | - | - | Stock option (right to buy) | |
| Rithm Cap Corp | Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 31,410 | 31,410 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Chimera Investment Corp | Miyun Sung | Chief Legal Officer & Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 31,164 | 67,958 (0%) | 0% | 0 | Common Stock | |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 31.77 per share. | 20 Jan 2026 | 30,433 | 522,344 | - | 31.8 | 966,856 | Class A Common Stock |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.52 per share. | 20 Jan 2026 | 30,328 | 1,964,660 | - | 18.5 | 561,675 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.52 per share. | 20 Jan 2026 | 30,000 | 42,976 (0%) | 0% | 3.5 | 105,450 | Common Stock |
| JPMC | Mary Callahan Erdoes | CEO Asset & Wealth Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 29,364 | 29,364 | - | - | Restricted Stock Units | |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.66 per share. | 20 Jan 2026 | 29,112 | 1,995,876 | - | 20.7 | 601,454 | Common Stock |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 20 Jan 2026 | 29,038 | 1,920,950 | - | 18.1 | 524,136 | Common Stock |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 27,921 | 55,843 | - | - | Restricted Stock Unit | |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 27,921 | 132,763 | - | 0 | Class A Common Stock | |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.80 per share. | 20 Jan 2026 | 27,505 | 3,517,566 (44%) | 0% | 10.8 | 297,054 | Common Stock |
| Hewlett Packard | Marie Myers | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.39 per share. | 20 Jan 2026 | 27,330 | 243,815 (0%) | 0% | 20.4 | 557,259 | Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 27,200 | 163,200 | - | - | Employee Stock Option (right to buy) | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.18 per share. | 20 Jan 2026 | 27,200 | 692,645 (0%) | 0% | 23.2 | 630,496 | Common Stock |
| Citigroup | Anand Selvakesari | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 27,154 | 202,025 (0%) | 0% | 118.0 | 3,205,315 | Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 94.78 per share. | 20 Jan 2026 | 26,772 | 310,311 | - | 94.8 | 2,537,431 | Class A Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 26,575 | 26,575 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 26,575 | 121,661 (0%) | 0% | - | Common Stock | |
| Siebert Fin Corp | John J. Gebbia | Member of 10% owner group | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 26,000 | 516,000 (1%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Siebert Fin Corp | John J. Gebbia | Member of 10% owner group | Other type of transaction at price $ 0.00 per share. | 20 Jan 2026 | 26,000 | 490,000 (1%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| JPMC | Douglas B. Petno | Co-CEO CIB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 25,938 | 25,938 | - | - | Restricted Stock Units | |
| JPMC | Troy L. Rohrbaugh | Co-CEO CIB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 25,938 | 25,938 | - | - | Restricted Stock Units | |
| Lennar (Class A) | Stuart A. Miller | Director, Executive Chairman & CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.16 per share. | 20 Jan 2026 | 25,913 | 1,168,244 (0%) | 0% | 115.2 | 2,984,141 | Class A Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 20 Jan 2026 | 25,000 | 175,000 | - | 0.9 | 21,500 | Class A Common Stock |
| Cloudastructure Inc (Class A) | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 20 Jan 2026 | 25,000 | 150,000 | - | 0.8 | 20,500 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 25,000 | 4,066,020 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 25,000 | 5,800,000 | - | - | Class B Common Stock | ||
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.09 per share. | 20 Jan 2026 | 25,000 | 229,310 (0%) | 0% | 1.1 | 27,250 | Common Shares |
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 25,000 | 0 | - | - | Options | |
| Syntec Optics Holdings Inc (Class A) | Brent D. Rosenthal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 24,646 | 101,966 | - | - | Restricted Stock Units | |
| Syntec Optics Holdings Inc (Class A) | Albert A. Manzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 24,646 | 101,966 | - | - | Restricted Stock Units | |
| Syntec Optics Holdings Inc (Class A) | Wally Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 24,646 | 101,966 | - | - | Restricted Stock Units | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.80 per share. | 20 Jan 2026 | 24,362 | 58,382 | - | 33.8 | 823,436 | Ordinary Shares |
| Stitch Fix Inc (Class A) | David Aufderhaar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.13 per share. | 20 Jan 2026 | 24,114 | 1,251,862 (2%) | 0% | 5.1 | 123,618 | Class A Common Stock |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 20 Jan 2026 | 24,002 | 297,214 | - | 1.3 | 30,723 | Common Stock |
| Natera Inc | Michael Brophy | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 23,948 | 99,776 (0%) | 0% | 234.7 | 5,621,515 | Common Stock |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 23,909 | 24,603 | - | - | Restricted Stock Unit | |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 23,909 | 495,195 (0%) | 0% | 0 | Common | |
| Natera Inc | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 23,205 | 144,992 (0%) | 0% | 234.7 | 5,447,105 | Common Stock |
| Sequans Comm S.A (ADR) | Daniel Asher | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 20 Jan 2026 | 22,600 | 1,895,678 (2%) | 0% | 5.2 | 118,431 | Common Stock |
| DraftKings Inc (Class A) | R. Stanton Dodge | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 20 Jan 2026 | 22,344 | 500,000 | - | 32.3 | 722,382 | Class A Common Stock |
| Neogenomics Inc | Warren C. Stone | Pres & Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 20 Jan 2026 | 22,128 | 121,631 (0%) | 0% | 12.5 | 276,682 | Common Stock |
| Morgan Stanley | Eric F. Grossman | Chief Legal/Admin Officer | Sale of securities on an exchange or to another person at price $ 184.00 per share. | 20 Jan 2026 | 21,555 | 171,005 (0%) | 0% | 184.0 | 3,966,137 | Common Stock |
| JPMC | Marianne Lake | CEO CCB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 21,534 | 21,534 | - | - | Restricted Stock Units | |
| Citigroup | Zdenek Turek | Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 21,469 | 206,418 (0%) | 0% | 118.0 | 2,534,262 | Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.61 per share. | 20 Jan 2026 | 21,433 | 202,768 (0%) | 0% | 51.6 | 1,106,157 | Common Shares |
| SouthState Corp | John C. Corbett | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 21,412 | 83,743 | - | - | Performance Share Units | |
| JPMC | Jennifer A Piepszak | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 21,289 | 21,289 | - | - | Restricted Stock Units | |
| American Eagle Outfitters Inc | Jay L. Schottenstein | Director, Exec Chairman & CEO | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 20 Jan 2026 | 21,236 | 6,386,995 (3%) | 0% | 26.2 | 556,935 | Common Stock, without par value |
| Copart | A. Jayson Adair | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 21,200 | 254,400 (0%) | 0% | 0 | Common Stock | |
| Copart | A. Jayson Adair | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 21,200 | 318,000 (0%) | 0% | 0 | Common Stock | |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,834 | 2,882,058 (1%) | 0% | 0 | Common Stock | |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.80 per share. | 20 Jan 2026 | 20,833 | 26,728 (0%) | 0% | 22.8 | 474,992 | Class A Common Stock |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 20,833 | 0 | - | - | Stock Option (Right to Buy) | |
| Amalgamated Fin Corp | Priscilla Sims Brown | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,816 | 284,163 (0%) | 0% | 0 | Common Stock | |
| Lennar (Class A) | Diane J. Bessette | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,625 | 325,114 (0%) | 0% | 0 | Class A Common Stock | |
| Lennar (Class A) | Diane J. Bessette | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,625 | 345,739 (0%) | 0% | 0 | Class A Common Stock | |
| Innovative Industrial Properties Inc | David Smith | CFO AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,061 | 23,582 (0%) | 0% | - | Common Stock | |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 20 Jan 2026 | 20,000 | 2,650,579 (3%) | 0% | 8.2 | 163,600 | Class A Common Stock |
| Morgan Stanley | Michael A. Pizzi | Head Technology & Operations | Sale of securities on an exchange or to another person at price $ 184.55 per share. | 20 Jan 2026 | 20,000 | 127,872 (0%) | 0% | 184.6 | 3,691,000 | Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 96.51 per share. | 20 Jan 2026 | 19,770 | 249,096 | - | 96.5 | 1,907,945 | Class A Common Stock |
| Citigroup | Syed Shahmir Khaliq | Head of Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 19,671 | 84,656 (0%) | 0% | 118.0 | 2,322,045 | Common Stock |
| Sequans Comm S.A (ADR) | Daniel Asher | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 20 Jan 2026 | 19,660 | 1,873,078 (1%) | 0% | 5.3 | 104,082 | Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.38 per share. | 20 Jan 2026 | 19,604 | 58,382 | - | 32.4 | 634,778 | Ordinary Shares |
| Natera Inc | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 19,234 | 226,615 (0%) | 0% | 234.7 | 4,514,958 | Common Stock |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.01 per share. | 20 Jan 2026 | 18,545 | 8,183 (0%) | 0% | 29.0 | 537,990 | Class A Common Stock |
| Biomarin pharma Inc - Registered Shares | Rashmi Virendra Ramchandani | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 18,540 | 18,540 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Rashmi Virendra Ramchandani | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 18,220 | 18,220 | - | - | Stock Option (Right to Buy Common Stock) | |
| Citigroup | Brent McIntosh | Chief Legal Off. & Corp. Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 18,145 | 95,693 (0%) | 0% | 118.0 | 2,141,871 | Common Stock |
| JPMC | Ashley Bacon | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 18,108 | 18,108 | - | - | Restricted Stock Units | |
| JPMC | Stacey Friedman | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 18,108 | 18,108 | - | - | Restricted Stock Units | |
| JPMC | Jeremy Barnum | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 18,108 | 18,108 | - | - | Restricted Stock Units | |
| Natera Inc | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale of securities on an exchange or to another person at price $ 234.74 per share. | 20 Jan 2026 | 17,806 | 177,591 (0%) | 0% | 234.7 | 4,179,752 | Common Stock |
| TKO (Class A) | Andrew M. Schleimer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 17,540 | 34,903 | - | - | Restricted Stock Unit | |
| TKO (Class A) | Andrew M. Schleimer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 17,450 | 39,522 | - | 0 | Class A Common Stock | |
| Rivian Automotive Inc (Class A) | Robert J. Scaringe | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 20 Jan 2026 | 17,450 | 1,115,209 | - | 16.0 | 279,762 | Class A Common Stock |
| ICF Intl Inc | John Wasson | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 17,272 | 17,503 (0%) | 0% | 0 | Common | |
| Neuphoria Therapeutics Inc | Alan Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 17,073 | 30,731 | - | - | Restricted Stock Units | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 20 Jan 2026 | 16,928 | 457,463 | - | 4.9 | 82,270 | Common Stock |
| Republic Bancorp Inc KY | Logan M. Pichel | Director, PRESIDENT & CEO, REPUBLIC BANK | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,903 | 16,903 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Daniel Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,833 | 16,833 | - | - | Stock Option (right to buy) | |
| Citigroup | Ernesto Torres Cantu | Head of International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 16,647 | 148,121 (0%) | 0% | 118.0 | 1,965,118 | Common Stock |
| Prologis | Daniel S. Letter | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,573 | 371,769 | - | - | LTIP Units | |
| Citigroup | Gonzalo Luchetti | Head of U.S. Personal Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 16,492 | 74,611 (0%) | 0% | 118.0 | 1,946,752 | Common Stock |
| Citigroup | Edward Skyler | Hd of Ent Svc & Public Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 16,415 | 188,311 (0%) | 0% | 118.0 | 1,937,656 | Common Stock |
| Protara Therapeutics Inc | Jesse Shefferman | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 20 Jan 2026 | 16,322 | 1,030,564 (17%) | 0% | 5.6 | 91,403 | Common Stock |
| Cricut Inc (Class A) | Kimball Shill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,249 | 1,436,900 | - | 0 | Class A Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 16,219 | 16,219 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 16,219 | 120,384 (0%) | 0% | - | Common Stock | |
| PPL | Vincent Sorgi | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.91 per share. | 20 Jan 2026 | 16,001 | 478,837 (0%) | 0% | 36.9 | 590,597 | Common Stock |
| Airgain Inc | Jacob Suen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 20 Jan 2026 | 15,993 | 293,635 (3%) | 0% | 4.0 | 63,908 | Common Stock |
| GigaCloud Tech Inc (Class A) | Larry Lei Wu | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.66 per share. | 20 Jan 2026 | 15,952 | 682,138 | - | 40.7 | 648,608 | Class A Ordinary Shares, par value $0.05 per share |
| Morgan Stanley | Sharon Yeshaya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 185.77 per share. | 20 Jan 2026 | 15,838 | 135,304 (0%) | 0% | 185.8 | 2,942,176 | Common Stock |
| Citigroup | Sara Wechter | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 15,490 | 92,414 (0%) | 0% | 118.0 | 1,828,520 | Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.25 per share. | 20 Jan 2026 | 15,422 | 82,744 | - | 33.3 | 512,782 | Ordinary Shares |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 15,213 | 106,448 (0%) | 0% | 4.0 | 61,308 | Common Stock |
| Citigroup | Sunil Garg | CEO, Citibank, N.A. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 15,199 | 124,797 (0%) | 0% | 118.0 | 1,794,193 | Common Stock |
| DoorDash | Prabir Adarkar | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.16 per share. | 20 Jan 2026 | 15,000 | 889,130 | - | 7.2 | 107,400 | Class A Common Stock |
| DoorDash | Prabir Adarkar | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 15,000 | 83,550 | - | - | Stock Option (right to buy) | |
| Rithm Cap Corp | David Zeiden | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 14,957 | 14,957 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Precision Biosciences Inc | Dario Scimeca | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 14,908 | 53,569 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Dario Scimeca | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 14,908 | 14,907 | - | - | Restricted Stock Units | |
| Benchmark Electronics Inc | Benck Jeff | Director, CEO | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 20 Jan 2026 | 14,900 | 423,180 (1%) | 0% | 50.2 | 748,576 | Common Stock |
| Citigroup | Pamela Habner | Head of U.S. Consumer Cards | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 14,699 | 73,494 (0%) | 0% | 118.0 | 1,735,177 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 14,625 | 67,875 | - | - | Common Stock | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 20 Jan 2026 | 14,625 | 14,625 (0%) | 0% | 117.8 | 1,722,240 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 14,625 | 53,250 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 471.91 per share. | 20 Jan 2026 | 14,625 | 0 (0%) | 0% | 471.9 | 6,901,656 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 20 Jan 2026 | 14,625 | 14,625 (0%) | 0% | 117.8 | 1,722,240 | Common Stock |
| Enliven Therapeutics Inc | Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 26.90 per share. | 20 Jan 2026 | 14,509 | 745,188 | - | 26.9 | 390,285 | Common Stock |
| F.N.B. Corp | Vincent J. Delie | Director, Chairman, President, & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.36 per share. | 20 Jan 2026 | 14,446 | 1,895,770 (0%) | 0% | 17.4 | 250,783 | Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 93.79 per share. | 20 Jan 2026 | 14,416 | 337,083 | - | 93.8 | 1,352,121 | Class A Common Stock |
| TKO (Class A) | Mark S. Shapiro | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 201.98 per share. | 20 Jan 2026 | 14,363 | 118,400 | - | 202.0 | 2,901,039 | Class A Common Stock |
| EverQuote Inc (Class A) | Jayme Mendal | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 24.15 per share. | 20 Jan 2026 | 14,360 | 406,404 (3%) | 0% | 24.2 | 346,794 | Class A Common Stock |
| Prologis | Daniel S. Letter | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 14,295 | 386,064 | - | - | LTIP Units | |
| SouthState Corp | John C. Corbett | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 14,275 | 27,351 | - | - | Restricted Share Units | |
| TKO (Class A) | Nick Khan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,960 | 27,922 | - | - | Restricted Stock Unit | |
| TKO (Class A) | Nick Khan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,960 | 136,827 | - | 0 | Class A Common Stock | |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 13,938 | 166,009 (0%) | 0% | 36.9 | 514,484 | Common Stock |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,938 | 0 | - | - | Stock Unit (SIP) | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,900 | 13,901 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,900 | 95,086 (0%) | 0% | - | Common Stock | |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,852 | 441,259 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 20 Jan 2026 | 13,852 | 555,923 (1%) | 0% | 3.8 | 52,638 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 20 Jan 2026 | 13,852 | 542,071 (0%) | 0% | 5.3 | 73,970 | Class A Common Stock |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,641 | 455,111 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Stitch Fix Inc (Class A) | Casey OConnor | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 20 Jan 2026 | 13,641 | 625,712 (1%) | 0% | 3.8 | 51,836 | Class A Common Stock |
| Easterly Government Properties Inc | Darrell W. Crate | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 13,100 | 13,100 | - | - | LTIP Units | |
| Easterly Government Properties Inc | Michael P. Ibe | Director, EVP - Dev & Acquisitions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 13,100 | 13,100 | - | - | LTIP Units | |
| Aeluma Inc | Mark N. Tompkins | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.30 per share. | 20 Jan 2026 | 12,947 | 1,951,713 | - | 19.3 | 249,877 | Common Stock |
| JPMC | Lori A. Beer | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,725 | 12,725 | - | - | Restricted Stock Units | |
| Abeona Therapeutics Inc | Madhav Vasanthavada | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.29 per share. | 20 Jan 2026 | 12,610 | 318,619 (0%) | 0% | 5.3 | 66,658 | Common Stock |
| First Internet Bancorp | David B. Becker | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,566 | 432,810 (4%) | 0% | 0 | Common Stock | |
| Penguin Soln Inc | Mark W. Adams | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.96 per share. | 20 Jan 2026 | 12,513 | 963,183 (4%) | 0% | 20.0 | 249,759 | Common Stock |
| Minerals Tech Inc | D. J. Monagle | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,504 | 34,088 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Viant Tech Inc (Class A) | Tim Vanderhook | Director, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 9,144,775 | - | - | Class B Units | |
| Viant Tech Inc (Class A) | Tim Vanderhook | Director, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 12,500 | - | 0 | Class A Common Stock | |
| Viant Tech Inc (Class A) | Tim Vanderhook | Director, CEO and Chairman, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 9,144,775 | - | 0 | Class B Common Stock | |
| Viant Tech Inc (Class A) | Chris Vanderhook | Director, Chief Operating Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 12,500 | - | 0 | Class A Common Stock | |
| Viant Tech Inc (Class A) | Chris Vanderhook | Director, Chief Operating Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 9,144,775 | - | 0 | Class B Common Stock | |
| Viant Tech Inc (Class A) | Chris Vanderhook | Director, Chief Operating Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,500 | 9,144,775 | - | - | Class B Units | |
| Prologis | Hamid R. Moghadam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,365 | 1,105,099 | - | - | LTIP Units | |
| Comcast (Class A) | Thomas J. Reid | Chief Legal Officer, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,319 | 32,852 | - | - | Restricted Stock Units | |
| Comcast (Class A) | Thomas J. Reid | Chief Legal Officer, Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 12,319 | 135,008 (0%) | 0% | 0 | Class A Common Stock | |
| Citigroup | Titilope Cole | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 12,136 | 60,111 (0%) | 0% | 118.0 | 1,432,548 | Common Stock |
| Nicolet Bankshares Inc | Michael E. Daniels | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 131.43 per share. | 20 Jan 2026 | 12,125 | 122,757 (1%) | 0% | 131.4 | 1,593,589 | Common Stock |
| Minerals Tech Inc | Brett Argirakis | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,101 | 30,603 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Gamestop Corp (Class A) | Alain Attal | Director | Purchase of securities on an exchange or from another person at price $ 20.90 per share. | 20 Jan 2026 | 12,000 | 584,464 (0%) | 0% | 20.9 | 250,798 | Class A Common Stock |
| TKO (Class A) | Andrew M. Schleimer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 201.98 per share. | 20 Jan 2026 | 11,978 | 27,544 | - | 202.0 | 2,419,316 | Class A Common Stock |
| Coherus Biosciences Inc | Dennis M. Lanfear | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 20 Jan 2026 | 11,839 | 673,235 (0%) | 0% | 1.5 | 18,350 | Common Stock |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 20 Jan 2026 | 11,794 | 107,823 | - | 5.1 | 60,385 | Common Stock |
| PLAYSTUDIOS Inc (Class A) | Scott Peterson | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 20 Jan 2026 | 11,532 | 95,948 | - | 0 | Class A Common Stock | |
| Morgan Stanley | Andrew M. Saperstein | Co-President | Sale of securities on an exchange or to another person at price $ 181.85 per share. | 20 Jan 2026 | 11,430 | 299,380 (0%) | 0% | 181.9 | 2,078,566 | Common Stock |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 129.25 per share. | 20 Jan 2026 | 10,756 | 15,383 (0%) | 0% | 129.3 | 1,390,266 | Common Stock |
| Minerals Tech Inc | D. J. Monagle | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,739 | 10,739 | - | - | Employee Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,447 | 104,165 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,447 | 10,447 | - | - | Restricted Stock Units | |
| Minerals Tech Inc | Brett Argirakis | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,393 | 10,393 | - | - | Employee Stock Option (Right to Buy) | |
| Prologis | Damon Austin | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,320 | 153,554 | - | - | LTIP Units | |
| Prologis | Timothy D. Arndt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,301 | 290,242 | - | - | LTIP Units | |
| ADTRAN Holdings Inc | Thomas R. Stanton | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share. | 20 Jan 2026 | 10,247 | 971,848 (2%) | 0% | 9.2 | 94,682 | Common Stock |
| Precision Biosciences Inc | Jeff Smith | Chief Research Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 10,200 | 110,184 (0%) | 0% | 4.0 | 41,106 | Common Stock |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.55 per share. | 20 Jan 2026 | 10,133 | 17,623,127 (17%) | 0% | 70.5 | 714,883 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.43 per share. | 20 Jan 2026 | 10,105 | 17,633,822 (17%) | 0% | 70.4 | 711,645 | Common Shares |
| Alx Oncology Holdings Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,100 | 10,100 | - | - | Stock option (right to buy) | |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 95.55 per share. | 20 Jan 2026 | 10,075 | 4,911 | - | 95.6 | 962,668 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 95.55 per share. | 20 Jan 2026 | 10,074 | 4,912 | - | 95.6 | 962,573 | Class A Common Stock |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.32 per share. | 20 Jan 2026 | 10,005 | 485,190 (0%) | 0% | 201.3 | 2,014,207 | Common |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 20 Jan 2026 | 10,000 | 147,486 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 20 Jan 2026 | 10,000 | 8,925 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 18,925 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 80,341 | - | - | Employee Stock Option (right to buy) | |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 20 Jan 2026 | 10,000 | 100,270 (0%) | 0% | 19.1 | 190,800 | Common Stock |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 20 Jan 2026 | 10,000 | 90,270 (0%) | 0% | 27.3 | 273,420 | Common Stock |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 20 Jan 2026 | 10,000 | 3,124,343 | - | 9 | 90,000 | Common Stock |
| Olema Pharma Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 20 Jan 2026 | 10,000 | 727,770 | - | 26.9 | 268,800 | Common Stock |
| Capital City Bank Grp Inc | William G. Smith | Director, CHAIRMAN, PRESIDENT & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 9,868 | 2,369,664 (14%) | 0% | 0 | Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,688 | 9,688 | - | - | Restricted Stock Unit | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,688 | 119,633 | - | 0 | Class A Common Stock | |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 9,650 | 69,681 (0%) | 0% | 36.9 | 356,190 | Common Stock |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,650 | 0 | - | - | Stock Unit (SIP) | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 128.01 per share. | 20 Jan 2026 | 9,600 | 26,139 (0%) | 0% | 128.0 | 1,228,918 | Common Stock |
| Prologis | Damon Austin | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 9,555 | 143,234 | - | - | LTIP Units | |
| H.B. Fuller Co | Celeste Beeks Mastin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 9,533 | 9,533 | - | - | Performance Stock Units | |
| SoFi Tech Inc | Kelli Keough | EVP, GBUL, SIPS | Sale of securities on an exchange or to another person at price $ 25.75 per share. | 20 Jan 2026 | 9,468 | 303,480 | - | 25.7 | 243,797 | Common Stock |
| Outset Medical Inc | John L. Brottem | General Counsel | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 20 Jan 2026 | 9,314 | 36,957 | - | 5.1 | 47,688 | Common Stock |
| TKO (Class A) | Seth D. Krauss | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,307 | 16,287 | - | 0 | Class A Common Stock | |
| TKO (Class A) | Seth D. Krauss | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,307 | 18,615 | - | - | Restricted Stock Unit | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.68 per share. | 20 Jan 2026 | 9,300 | 80,100 | - | 32.7 | 303,911 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.68 per share. | 20 Jan 2026 | 9,273 | 80,127 | - | 32.7 | 303,064 | Class A Common Stock |
| SBA Communications (Class A) | Joshua M. Koenig | EXECUTIVE VP/GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,121 | 0 | - | - | Stock Options (Right to Buy) | |
| SBA Communications (Class A) | Joshua M. Koenig | EXECUTIVE VP/GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.30 per share. | 20 Jan 2026 | 9,121 | 14,682 (0%) | 0% | 182.3 | 1,662,758 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 20 Jan 2026 | 9,067 | 91,617 | - | 30.3 | 275,114 | Class A Common Stock |
| Target Hospitality Corp (Class A) | Heidi Diane Lewis | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 20 Jan 2026 | 9,000 | 131,742 (0%) | 0% | 7.3 | 66,060 | Common Stock, par value $0.0001 per share |
| Kinder Morgan (Class P) | Amy W. Chronis | Director | Grant, award, or other acquisition of securities at price $ 27.96 per share. | 20 Jan 2026 | 8,950 | 48,001 (0%) | 0% | 28.0 | 250,242 | Class P Common Stock |
| Capital City Bank Grp Inc | William G. Smith | Director, CHAIRMAN, PRESIDENT & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,904 | 2,378,568 (14%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,888 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Michael Amoroso | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,888 | 124,463 (0%) | 0% | - | Common Stock | |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 70.55 per share. | 20 Jan 2026 | 8,867 | 2,085,867 (2%) | 0% | 70.6 | 625,567 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.55 per share. | 20 Jan 2026 | 8,867 | 2,085,867 (2%) | 0% | 70.6 | 625,567 | Common Shares |
| Precision Biosciences Inc | Dario Scimeca | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Jan 2026 | 8,854 | 44,715 (0%) | 0% | 4.0 | 35,682 | Common Stock |
| Urban Outfitters Inc | Margaret A. Hayne | Director, Co-President & CCO | Sale of securities on an exchange or to another person at price $ 70.42 per share. | 20 Jan 2026 | 8,843 | 2,095,224 (2%) | 0% | 70.4 | 622,768 | Common Shares |
| Urban Outfitters Inc | Richard A. Hayne | Director, CEO & Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 70.42 per share. | 20 Jan 2026 | 8,843 | 2,095,224 (2%) | 0% | 70.4 | 622,768 | Common Shares |
| SBA Communications (Class A) | Joshua M. Koenig | EXECUTIVE VP/GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.11 per share. | 20 Jan 2026 | 8,800 | 5,882 (0%) | 0% | 194.1 | 1,708,168 | Class A Common Stock |
| Capital City Bank Grp Inc | Thomas A. Barron | Director, TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,770 | 152,067 (0%) | 0% | 0 | Common Stock-Direct | |
| Citigroup | Andrew John Morton | Head of Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 8,740 | 402,433 (0%) | 0% | 118.1 | 1,031,765 | Common Stock |
| Lennar (Class A) | David M. Collins | VP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,687 | 52,630 (0%) | 0% | 0 | Class A Common Stock | |
| Lennar (Class A) | Katherine Lee Martin | Chief Legal Officer/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,683 | 59,566 (0%) | 0% | 0 | Class A Common Stock | |
| Lennar (Class A) | Katherine Lee Martin | Chief Legal Officer/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,683 | 50,883 (0%) | 0% | 0 | Class A Common Stock | |
| Protagonist Therapeutics Inc | Asif Ali | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.48 per share. | 20 Jan 2026 | 8,588 | 78,077 (0%) | 0% | 82.5 | 708,338 | Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.10 per share. | 20 Jan 2026 | 8,567 | 194,201 (0%) | 0% | 52.1 | 446,341 | Common Shares |
| JPMC | Robin Leopold | Head of Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,565 | 8,565 | - | - | Restricted Stock Units | |
| Minerals Tech Inc | Erik Aldag C. | SVP FINANCE AND TREASURY, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,557 | 21,616 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Neuphoria Therapeutics Inc | Peter Miles Davies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,320 | - | - | Restricted Stock Units | |
| Neuphoria Therapeutics Inc | Jane Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,550 | - | - | Restricted Stock Units | |
| Neuphoria Therapeutics Inc | David Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,412 | - | - | Restricted Stock Units | |
| Morgan Stanley | Charles Aubrey Smith | Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 182.08 per share. | 20 Jan 2026 | 8,500 | 119,127 (0%) | 0% | 182.1 | 1,547,686 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Sale of securities on an exchange or to another person at price $ 303.38 per share. | 20 Jan 2026 | 8,500 | 487,344 (1%) | 0% | 303.4 | 2,578,730 | Common Stock |
| Precision Biosciences Inc | Dario Scimeca | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,425 | 38,661 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | Dario Scimeca | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,425 | 8,425 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.15 per share. | 20 Jan 2026 | 8,370 | 1,554,000 | - | 33.1 | 277,460 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 8,335 | 8,335 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brannin McBee | Chief Development Officer | 20 Jan 2026 | 8,335 | 933,320 | - | - | Class B Common Stock | ||
| American Battery Tech Co | Scott H. Jolcover | Chief Mineral Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,333 | 353,925 (0%) | 0% | 0 | Common Stock | |
| Heritage Insurance Holdings Inc | Ernesto Garateix | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.02 per share. | 20 Jan 2026 | 8,234 | 1,128,604 (3%) | 0% | 26.0 | 214,249 | Common Stock |
| JPMC | Elena A. Korablina | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,157 | 8,157 | - | - | Restricted Stock Units | |
| Comcast (Class A) | Armstrong Jason | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,150 | 23,044 | - | - | Restricted Stock Units | |
| Comcast (Class A) | Armstrong Jason | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 8,150 | 47,204 (0%) | 0% | 0 | Class A Common Stock | |
| Prologis | Timothy D. Arndt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,133 | 279,941 | - | - | LTIP Units | |
| First Internet Bancorp | Nicole S. Lorch | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,084 | 78,449 (0%) | 0% | 0 | Common Stock | |
| MediaAlpha Inc (Class A) | Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.02 per share. | 20 Jan 2026 | 8,000 | 2,767,330 | - | 11.0 | 88,182 | Class A Common Stock |
| MediaAlpha Inc (Class A) | Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 20 Jan 2026 | 8,000 | 2,775,330 | - | 11.2 | 89,634 | Class A Common Stock |
| MediaAlpha Inc (Class A) | Steven M. Yi | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 20 Jan 2026 | 8,000 | 2,759,330 | - | 11.2 | 89,616 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.16 per share. | 20 Jan 2026 | 7,976 | 1,554,000 | - | 33.2 | 264,451 | Class A Common Stock |
| SouthState Corp | Stephen Dean Young | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,886 | 29,018 | - | - | Performance Share Units | |
| Prologis | Carter H. Andrus | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,883 | 173,307 | - | - | LTIP Units | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,875 | 28,690 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,875 | 36,565 | - | - | Stock Options | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 471.91 per share. | 20 Jan 2026 | 7,875 | 0 (0%) | 0% | 471.9 | 3,716,276 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 20 Jan 2026 | 7,875 | 7,875 (0%) | 0% | 146.0 | 1,149,986 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 20 Jan 2026 | 7,875 | 7,875 (0%) | 0% | 146.0 | 1,149,986 | Common Stock |
| MP Materials Corp | Elliot Dean Hoops | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 68.21 per share. | 20 Jan 2026 | 7,823 | 74,967 | - | 68.2 | 533,607 | Common Stock |
| Copart | A. Jayson Adair | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 7,761 | 14,174,859 (6%) | 0% | 0 | Common Stock | |
| Reddit Inc (Class A) | Jennifer L. Wong | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 225.69 per share. | 20 Jan 2026 | 7,760 | 1,166,777 | - | 225.7 | 1,751,354 | Class A Common Stock |
| TKO (Class A) | Nick Khan | Director | Sale of securities on an exchange or to another person at price $ 201.98 per share. | 20 Jan 2026 | 7,744 | 129,083 | - | 202.0 | 1,564,133 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.19 per share. | 20 Jan 2026 | 7,665 | 375,585 (0%) | 0% | 118.2 | 905,916 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.19 per share. | 20 Jan 2026 | 7,665 | 375,585 (0%) | 0% | 118.2 | 905,916 | Class A Common Stock |
| Prologis | Hamid R. Moghadam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,644 | 1,112,743 | - | - | LTIP Units | |
| Columbia Banking System Inc | Clint E. Stein | Director, Chair, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.35 per share. | 20 Jan 2026 | 7,615 | 131,758 (0%) | 0% | 28.3 | 215,885 | Common Stock |
| Waystar Holding Corp | Eric L. Sinclair III | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.19 per share. | 20 Jan 2026 | 7,562 | 482,388 | - | 18.2 | 137,553 | Common Stock |
| Waystar Holding Corp | Eric L. Sinclair III | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,562 | 173,938 | - | - | Stock Options (right to buy) | |
| Pliant Therapeutics Inc | Lily Cheung | Chief Human Resource Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 20 Jan 2026 | 7,534 | 44,847 | - | 1.3 | 9,644 | Common Stock |
| Minerals Tech Inc | Erik Aldag C. | SVP FINANCE AND TREASURY, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,349 | 7,349 | - | - | Employee Stock Option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 20 Jan 2026 | 7,317 | 98,934 | - | 5.0 | 36,658 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,317 | 149,313 | - | - | Stock Option (right to buy) | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,248 | 462,791 (0%) | 0% | 0 | Ordinary Shares | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,248 | 102,579 | - | - | Deferred Stock Units | |
| Arista Networks | Kenneth Duda | Director, President and CTO | Sale of securities on an exchange or to another person at price $ 127.28 per share. | 20 Jan 2026 | 7,237 | 35,739 (0%) | 0% | 127.3 | 921,122 | Common Stock |
| EverCommerce Inc | Eric Remer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.26 per share. | 20 Jan 2026 | 7,194 | 2,734,424 | - | 12.3 | 88,188 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.